During the past decade, Clinique Mathilde conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Mathilde" #1 sponsor was "The Lymphoma Academic Research Organisation" with 4 trials, followed by "Centre Hospitalier Universitaire Dijon" with 2 trials sponsored, "Institut Claudius Regaud" with 2 trials sponsored, "ARCAGY/ GINECO GROUP" with 1 trials sponsored and "Centre Francois Baclesse" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Mathilde" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Mathilde" are "Breast Cancer" (2 trials), "CHILD B" (1 trials), "Cancer" (1 trials), "Cardiovascular Diseases" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Clinique Mathilde" in a lesser frequency.

Most popular intervention types in "Clinique Mathilde" are "Drug" (15 trials), "Other" (3 trials), "Procedure" (3 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (1 trials), "Avelumab" (1 trials), "BEACOPPesc" (1 trials), "BEACOPPesc - ABVD - PET2" (1 trials) and "Bleomycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Mathilde" are 17 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Mathilde". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Clinique Mathilde, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Mathilde, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".